Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals.
Astrid M ChevanceAnneka TomlinsonPhilippe RavaudSuzanne TouboulCatherine HenshallViet-Thi TranAndrea CiprianiPublished in: Evidence-based mental health (2022)
The most important NSAEs should contribute to the core outcome set for harms in depression.